Systemic lupus erythematosus disease activity index 2000.
By D. Gladman, D. Ibañez, M. Urowitz. Journal of Rheumatology, 2002
3,354 citations recorded by the source corpus.
View Paper: https://www.semanticscholar.org/paper/d810a3fedb319804363262fb9300295a4ec9ccdc
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
- K. Kirou
- M. Crow
- Christina Lee
- Sandhya George
- Kyriakos Louca
- A. Sarkar
- S. Dutra
- M. Peterson
Citations in the corpus
- Gut Microbiota and Immune System Interactions (2020, background): “While the pathogenesis is not fully understood, a combination of environmental factors, host genetic background, and gut microbiota can contribute to SLE [122].”
- Activation of the interferon-alpha pathway identifies a subgroup of systemic lupus erythematosus patients with distinct serologic features and active disease. (2005, methodology): “Mean % monocytes (range)¶ 24.0 (2.4–64.7) 22.2 (10.2–40.4) 20.0 (8.8–42.4) 0.05 0.05 Mean IFN score (range) 4.26 (0–43) 0.59 (0–5) 0.50 (0–3) 0.01 0.01 * SLE systemic lupus erythematosus; NA not applicable; SLEDAI-2K SLE Disease Activity Index 2000; SDI Systemic Lupus International Collaborating Cli”